Orciprenaline-containing product
RxNorm 7688
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 7688 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Orciprenaline-containing product.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Metaproterenol
(Atom ID: 2976396)
PTPrescribable
Designated preferred name (PT):
Metaproterenol
(Atom ID: 247837)
PTPrescribable
Designated preferred name (PT):
Metaproterenol-containing product
(Atom ID: 10806881)
SYPrescribable
Synonym (SY):
Orciprenaline
(Atom ID: 2384877)
FNPrescribable
Full form of descriptor (FN):
Orciprenaline (substance)
(Atom ID: 9252364)
SYPrescribable
Synonym (SY):
Orciprenaline-containing product
(Atom ID: 10808345)
FNPrescribable
Full form of descriptor (FN):
Product containing orciprenaline (medicinal product)
(Atom ID: 9260689)
Patient Education
Metaproterenol
Metaproterenol is used to prevent and treat wheezing, shortness of breath, coughing, and chest tightness caused by asthma, chronic bronchitis, emphysema, and other lung diseases. It relaxes and opens air passages in the lungs, making it easier to breathe.
[Learn More]
* Please review the disclaimer below.